Rosiglitazone
Especificaciones
122320-73-4Número CAS
431-390-4Número CE
5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dioneNombre IUPAC
C18H19N3O3SFórmula química
357.4 g/molPeso molecular
rosiglitazone; 122320-73-4; Rosiglizole; Brl-49653; Rezult; rosiglitazona; Gaudil; Rosvel; BRL49653; rosiglitazonum; DTXSID7037131; 2,4-thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-; NSC-758698; 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione; 05V02F2KDG; TDZ-01; CHEBI:50122; 2,4-Thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-; 5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate; DTXCID5017131; 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione; 5-((4-(2-(methyl-pyridin-2-ylamino)ethoxy)phenyl)methyl)-1,3-thiazolidine-2,4-dione; 5-[[4-[2-(methyl-pyridin-2-ylamino)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione; RefChem:56529; A10BG02; Avandia; 5-(4-(2-(Methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione; Brl 49653; Avandamet; Avandaryl; TDZ 01; Rosiglitazone base; MFCD00871760; 5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione; 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione; Rosiglitazone (INN); NCGC00095124-01; S2556; ROSIGLITAZONE [INN]; 5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione; rosiglitazone (Avandia); Rosiglitazone [INN:BAN]; 5-(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}benzyl)-1,3-thiazolidine-2,4-dione; CAS-122320-73-4; SR-01000763023; UNII-05V02F2KDG; Rosigltazone; HSDB 7555; 5-[4-[2-[N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione; Gaudil (TN); Spectrum_001703; Rosiglitazone (Standard); 1217260-35-9; Spectrum2_001241; Spectrum3_000997; Spectrum4_001125; Spectrum5_001464; ROSIGLITAZONE [MI]; SCHEMBL5169; ROSIGLITAZONE [HSDB]; ROSIGLITAZONE [IARC]; BSPBio_002693; KBioGR_001609; KBioSS_002183; ROSIGLITAZONE [VANDF]; ROSIGLITAZONE [MART.]; SPECTRUM1504263; SPBio_001142; ROSIGLITAZONE [WHO-DD]; GTPL1056; orb1226757; orb1310711; ROSIGLITAZONE [EMA EPAR]; SCHEMBL14383595; SCHEMBL14383596; SCHEMBL29530259; KBio2_002183; KBio2_004751; KBio2_007319; KBio3_001913; Rosiglitazone - Bio-X trade mark; Rosiglitazone, >=98% (HPLC); BDBM723998; GLXC-06376; HMS1922J11; HMS2094O13; HMS3649G08; HMS3656K16; HMS3744M11; HMS3871L03; HMS3884N08; HMS5081F03; Pharmakon1600-01504263; MSK11057; Tox21_111434; 5-[4-[2-[Methyl(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione; BDBM50030474; CCG-39102; EBC-14154; HB2556; HY-17386R; NSC758698; STL350047; 5-[[4-[2-[methyl(2-pyridyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione; AKOS015894872; O-De-Me, 2-O-B-D-galactopyranoside; Tox21_111434_1; AC-3459; DB00412; FR39350; NSC 758698; SB17326; NCGC00095124-02; NCGC00095124-03; NCGC00095124-04; NCGC00095124-05; NCGC00095124-06; NCGC00095124-08; NCGC00095124-33; BR164372; HY-17386; SY031184; US20250064791, Compound Rosiglitazone; NS00008920; R0106; R5773; SW197573-6; 6P-065; D08491; S00306; AB00698473-15; AB00698473-17; AB00698473-18; AB00698473-19; AB00698473_20; AB00698473_21; AB00698473_22; AB00698473_23; F093413; Q424771; SR-01000763023-5; SR-01000763023-6; BRD-A97437073-001-02-3; BRD-A97437073-001-03-1; BRD-A97437073-001-04-9; BRD-A97437073-001-08-0; BRD-A97437073-003-14-4; BRD-A97437073-050-13-7; BRD-A97437073-050-14-5; SR-01000763023-12; (RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion; 5-(4-(2-(Methyl(pyridin-2-yl)amino)ethoxy)-benzyl)thiazolidine-2,4-dione; 5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4dione; (+/-)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione; 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- (9CI); 5-(4-(2-(N-METHYL-N-(2-PYRIDINYL)AMINO)ETHOXY)BENZYL)-2,4-THIAZOLIDINEDIONE; 5-[[4-[2-(methyl-(2-pyridyl)amino)ethoxy]phenyl]methyl] thiazolidine-2,4-dione; 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy]phenyl]methyl]-2,4-thiazolidinedione; 5-[[4-[2-(Methyl-2-pyridinylamino)e thoxy]phenyl]methyl]-2,4-thiazolidinedione; 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione; 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]phenyl methyl]thiazolidine-2,4-dione; BRL 49653; BRL49653; BRL-49653; 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedioneSinónimos